08.10.2015 Views

Opioid-Induced Constipation Treatment Market-Segments and Forecasts up to 2023

Opioids are a class of drugs that are generally used as pain relievers. These drugs are derived from opium, which are produced by a plant called Poppy (Papaver somniferum). Opioids are known by variety of names such as opiates and narcotics. Use of opioids produces a sense of euphoria and wellbeing, which can be addictive to some people. Moreover, prolonged use of opioids can lead to the damage of nervous system that causes body cells to stop producing endogenous opioids such as endorphins. Moreover, opioids are known to affect the gastrointestinal tract in a variety of ways. Opioids reduce the secretions of digestive juices thus decreasing the urge to defecate. Opioid-based therapies are prescribed to advanced cancer patients to reduce their pain and increase their quality of life. Currently, the opioid induced constipation treatment market is a highly attractive and promising market due to the increasing base of OIC sufferers.

Opioids are a class of drugs that are generally used as pain relievers. These drugs are derived from opium, which are produced by a plant called Poppy (Papaver somniferum). Opioids are known by variety of names such as opiates and narcotics. Use of opioids produces a sense of euphoria and wellbeing, which can be addictive to some people. Moreover, prolonged use of opioids can lead to the damage of nervous system that causes body cells to stop producing endogenous opioids such as endorphins. Moreover, opioids are known to affect the gastrointestinal tract in a variety of ways. Opioids reduce the secretions of digestive juices thus decreasing the urge to defecate. Opioid-based therapies are prescribed to advanced cancer patients to reduce their pain and increase their quality of life. Currently, the opioid induced constipation treatment market is a highly attractive and promising market due to the increasing base of OIC sufferers.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Opioid</strong>-<strong>Induced</strong> <strong>Constipation</strong> (OIC) <strong>Treatment</strong><br />

<strong>Market</strong> - Global Industry Analysis, Size, Share,<br />

Growth, Trends <strong>and</strong> Forecast 2015 - <strong>2023</strong><br />

Single User License:<br />

USD 4315.5<br />

<br />

<br />

<br />

<br />

Flat 10% Discount!!<br />

Free Cus<strong>to</strong>mization as per your requirement<br />

You will get Cus<strong>to</strong>m Report at Syndicated Report<br />

price<br />

Report will be delivered with in 15-20 working days<br />

Transparency <strong>Market</strong> Research<br />

State Tower,<br />

90, State Street, Suite 700.<br />

Albany, NY 12207<br />

United States<br />

www.transparencymarketresearch.com<br />

sales@transparencymarketresearch.com<br />

Request Sample<br />

Buy Now


REPORT DESCRIPTION<br />

<strong>Opioid</strong>s are a class of drugs that are generally used as pain relievers. These drugs are derived from opium, which are produced by a plant called<br />

Poppy (Papaver somniferum). <strong>Opioid</strong>s are known by variety of names such as opiates <strong>and</strong> narcotics. Use of opioids produces a sense of e<strong>up</strong>horia<br />

<strong>and</strong> wellbeing, which can be addictive <strong>to</strong> some people. Moreover, prolonged use of opioids can lead <strong>to</strong> the damage of nervous system that causes<br />

body cells <strong>to</strong> s<strong>to</strong>p producing endogenous opioids such as endorphins. Moreover, opioids are known <strong>to</strong> affect the gastrointestinal tract in a variety<br />

of ways. <strong>Opioid</strong>s reduce the secretions of digestive juices thus decreasing the urge <strong>to</strong> defecate. <strong>Opioid</strong>-based therapies are prescribed <strong>to</strong><br />

advanced cancer patients <strong>to</strong> reduce their pain <strong>and</strong> increase their quality of life. Currently, the opioid induced constipation treatment market is a<br />

highly attractive <strong>and</strong> promising market due <strong>to</strong> the increasing base of OIC sufferers.<br />

Browse Full Report With TOC:- http://www.transparencymarketresearch.com/opioidinduced-constipation-treatment-market.html<br />

Some of the treatment regimens usually used for the treatment of opioid induced constipation are as follows:<br />

• Relis<strong>to</strong>r<br />

• Naloxegol<br />

• Amitiza oral<br />

• Methylnaltrexone subcutaneous<br />

• Targin<br />

Geographically, North America is the leading market for opioid induced constipation treatment due <strong>to</strong> the increasing base of OIC sufferers <strong>and</strong> illicit<br />

drug users. According <strong>to</strong> the National Institute on Drug Abuse, globally approximately 26.4 million <strong>to</strong> 36 million people abuse opioids. The<br />

organization also predicted that, in 2012, approximately 2.1 million people in the U.S. were suffering from drug substance use disorders associated<br />

with prescription opioid pain relievers. Moreover, it has also been observed that, globally the number of opioid pain reliever prescriptions has<br />

skyrocketed in the past two decades. The number of opiates prescription have shoot <strong>up</strong> from approximately 76 million in 1991 <strong>to</strong> around 207<br />

million in 2013; with the U.S. their largest end-user globally, accounting for about 100 percent of the planet <strong>to</strong>tal for hydrocodone <strong>and</strong><br />

approximately 80 percent for oxycodone. Furthermore, developing regions such as South East Asia, Latin America <strong>and</strong> Caribbean region are some<br />

of potential regions where introduction of effective opioid induced constipation therapies might boosts <strong>up</strong> the overall revenue of a particular<br />

pharmaceutical company, due <strong>to</strong> the increasing base of OIC sufferers.<br />

The primary fac<strong>to</strong>rs fueling the growth of the opioid-induced constipation (OIC) treatment market are escalating base of the illicit drug users <strong>and</strong><br />

prolonged use of opioids in the treatment of chronic pain. Moreover, increased awareness among patients <strong>and</strong> physicians for using non-laxative<br />

prescription options <strong>to</strong> treat opioid induced constipation would further drive the growth of the OIC treatment market in the near future. Additionally,<br />

introduction of oral, highly targeted peripherally acting mu-opioid recep<strong>to</strong>r antagonist (PAMORA) therapies such as Naloxegol, Relis<strong>to</strong>r <strong>and</strong><br />

Bevenopran would further drive the overall growth of this market. Moreover, limited number of approved drugs <strong>and</strong> recent approval of novel drug


such as Movantik (naloxegol) for the treatment of OIC might significantly boost the growth of the overall market. Moreover, it has been estimated<br />

that the untapped market for effective, convenient <strong>and</strong> safe drug therapy in OIC medicine is highly extensive <strong>and</strong> growing. However, high prices of<br />

novel medicines <strong>and</strong> high preference for st<strong>and</strong>ard laxative therapy along with unfavorable reimbursement policies by health insurance companies<br />

<strong>and</strong> local health authorities are expected <strong>to</strong> hinder the overall growth of the OIC treatment market.<br />

Currently, the opioid-induced constipation (OIC) treatment market is a highly lucrative <strong>and</strong> attractive market venture due <strong>to</strong> the increasing base of<br />

drug addicts <strong>and</strong> abusers. Some of the key players involved with the development <strong>and</strong> commercialization of opioid-induced constipation (OIC)<br />

treatment products are AIKO Biotechnology, Inc., AstraZeneca plc, Cubist Pharmaceuticals, Inc., Pfizer, Inc., Salix Pharmaceuticals, Inc., S.L.A.<br />

Pharma AG <strong>and</strong> Takeda Pharmaceutical Company Limited, amongst others.<br />

This research report analyzes this market on the basis of its market segments, major geographies, <strong>and</strong> current market trends. Geographies<br />

analyzed under this research report include<br />

<br />

<br />

<br />

<br />

<br />

North America<br />

Asia Pacific<br />

Europe<br />

Middle East <strong>and</strong> Africa<br />

Latin America<br />

This report provides comprehensive analysis of<br />

<br />

<br />

<br />

<br />

<br />

<strong>Market</strong> growth drivers<br />

Fac<strong>to</strong>rs limiting market growth<br />

Current market trends<br />

<strong>Market</strong> structure<br />

<strong>Market</strong> projections for <strong>up</strong>coming years<br />

This report is a complete study of current trends in the market, industry growth drivers, <strong>and</strong> restraints. It provides market projections for the coming<br />

years. It includes analysis of recent developments in technology, Porter’s five force model analysis <strong>and</strong> detailed profiles of <strong>to</strong>p industry players.<br />

The report also includes a review of micro <strong>and</strong> macro fac<strong>to</strong>rs essential for the existing market players <strong>and</strong> new entrants along with detailed value<br />

chain analysis.


Reasons for Buying this Report<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

This report provides pin-point analysis for changing competitive dynamics<br />

It provides a forward looking perspective on different fac<strong>to</strong>rs driving or restraining market growth<br />

It provides a six-year forecast assessed on the basis of how the market is predicted <strong>to</strong> grow<br />

It helps in underst<strong>and</strong>ing the key product segments <strong>and</strong> their future<br />

It provides pin point analysis of changing competition dynamics <strong>and</strong> keeps you ahead of competi<strong>to</strong>rs<br />

It helps in making informed business decisions by having complete insights of market <strong>and</strong> by making in-depth analysis of market segments<br />

It provides distinctive graphics <strong>and</strong> exemplified SWOT analysis of major market segments<br />

Request Brochure:- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6862<br />

More Pharmaceutical Reports: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html<br />

About Us<br />

Transparency <strong>Market</strong> Research is a market intelligence company providing global business information reports <strong>and</strong> services. Our exclusive blend<br />

of quantitative forecasting <strong>and</strong> trends analysis provides forward-looking insight for thous<strong>and</strong>s of decision makers.<br />

TMR’s experienced team of analysts, researchers, <strong>and</strong> consultants use proprietary data sources along with various <strong>to</strong>ols <strong>and</strong> techniques <strong>to</strong> gather<br />

<strong>and</strong> analyze information. Our business offerings represent the latest <strong>and</strong> the most reliable information which is indispensable for businesses <strong>to</strong><br />

sustain their competitive edge.<br />

Contact Us:-<br />

Transparency <strong>Market</strong> Research


90 State Street,<br />

Suite 700,<br />

Albany<br />

NY - 12207<br />

United States<br />

Tel: +1-518-618-1030<br />

USA - Canada Toll Free 866-552-3453<br />

Email: sales@transparencymarketresearch.com<br />

Website: http://www.transparencymarketresearch.com/<br />

Browse <strong>Market</strong> Research Blogs:<br />

https://keshabblog.wordpress.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!